Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Paralex Inc.
Appointments: Gyroscope, Urovant, Horizon, Modus, Allied Minds And Adherium
This week's roundup includes CEO appointments by Gyroscope Therapeutics, Urovant Sciences and Nevoii Pharmaceuticals, in addition to various other high-level appointments by companies including, Horizon Pharma, Veloxis Pharmaceuticals, Modus Therapeutics and Adherium.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.